Passage BIO PASG Income Statement (2019-2026)

NASDAQ PASG
$4.48 -0.03 (-0.67%)
At close: Aug 20, 2026 · 4:00 PM EDT
Income Statement Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Shares Outstanding (Entity) (Quarter)
2.70M2.71M2.72M2.72M2.73M2.73M2.73M2.74M2.74M2.75M3.08M3.09M3.09M3.10M3.11M3.18M3.18M3.18M3.21M3.22M
Operating items
Research & Development (Quarter)
26.62M32.97M26.21M26.82M15.36M17.66M16.84M17.32M15.10M12.16M11.54M10.43M8.66M9.56M7.74M5.81M4.31M5.42M4.09M3.34M
Selling, General & Administrative (Quarter)
14.98M17.19M15.10M12.99M10.66M10.59M19.05M8.06M8.18M6.29M6.51M6.51M7.25M4.71M6.08M4.52M4.35M4.92M4.79M6.87M
Other Operating Expenses (Quarter)
0.00M0.27M0.82M1.54M1.53M1.56M
Operating Expenses (Quarter)
41.60M50.16M41.31M39.81M26.03M28.24M35.88M25.39M23.28M18.45M18.05M16.94M15.91M14.27M13.82M10.33M8.65M10.34M8.88M10.22M
Operating Income (Quarter)
-47.10M-51.16M-42.81M-39.81M-27.53M-28.24M-35.88M-25.39M-28.67M-18.45M-18.05M-17.38M-20.70M-14.27M-16.46M-10.33M-8.65M-13.85M-8.25M-8.27M
EBIT (Quarter)
-47.10M-51.16M-42.81M-39.81M-27.53M-28.24M-35.88M-25.39M-28.67M-18.45M-18.05M-17.38M-20.70M-14.27M-16.46M-10.33M-8.65M-13.85M-8.25M-8.27M
Non-operating items
Non Operating Investment Income (Quarter)
Interest & Investment Income (Quarter)
0.19M-0.74M-0.92M-0.24M0.11M0.50M0.54M0.09M0.15M0.15M-0.03M0.00M0.10M-0.02M-0.01M
Other Non Operating Income (Quarter)
1.54M1.53M1.60M1.70M1.30M1.39M1.40M1.51M1.10M0.95M0.91M0.89M0.69M0.50M
Net income details
EBT (Quarter)
-50.47M-186.95M-94.08M-89.65M-48.88M-207.59M-55.50M-44.80M-73.90M-219.07M-62.16M-60.49M-36.94M-234.13M-31.56M-49.54M-46.87M-27.14M-15.69M-8.27M
Profit After Tax (Quarter)
-46.91M-51.20M-42.81M-39.54M-26.70M-27.07M-34.34M-23.86M-26.96M-17.53M-16.71M-15.99M-19.34M-12.72M-15.41M-9.38M-7.75M-12.98M-7.60M-7.82M
Income from Continuing Operations (Quarter)
-50.47M-186.95M-94.08M-89.65M-48.88M-207.59M-55.50M-44.80M-73.90M-219.07M-62.16M-60.49M-36.94M-234.13M-31.56M-49.54M-46.87M-27.14M-15.69M-8.27M
Consolidated Net Income (Quarter)
-50.47M-186.95M-94.08M-89.65M-48.88M-207.59M-55.50M-44.80M-73.90M-219.07M-62.16M-60.49M-36.94M-234.13M-31.56M-49.54M-46.87M-27.14M-15.69M-8.27M
Income towards Parent Company (Quarter)
-50.47M-186.95M-94.08M-89.65M-48.88M-207.59M-55.50M-44.80M-73.90M-219.07M-62.16M-60.49M-36.94M-234.13M-31.56M-49.54M-46.87M-27.14M-15.69M-8.27M
Net Income towards Common Stockholders (Quarter)
-50.47M-186.95M-94.08M-89.65M-48.88M-207.59M-55.50M-44.80M-73.90M-219.07M-62.16M-60.49M-36.94M-234.13M-31.56M-49.54M-46.87M-27.14M-15.69M-8.27M
Additional items
EPS (Basic) (Quarter)
-18.69-70.09-34.67-32.97-17.94-76.28-20.32-16.39-26.98-80.04-22.08-19.61-11.96-77.52-10.16-15.63-14.75-8.55-4.90-2.58
EPS (Diluted) (Quarter)
-18.69-70.09-34.67-32.97-17.94-76.28-20.32-16.39-26.98-80.04-22.08-19.61-11.96-77.52-10.16-15.63-14.75-8.55-4.90-2.58
Shares Outstanding (Quarter)
2.70M2.67M2.71M2.72M2.72M2.72M2.73M2.73M2.74M2.74M2.81M3.08M3.09M3.02M3.11M3.17M3.18M3.17M3.21M3.21M
Shares Outstanding (Diluted) (Quarter)
2.70M2.67M2.71M2.72M2.72M2.72M2.73M2.73M2.74M2.74M2.81M3.08M3.09M3.02M3.11M3.17M3.18M3.17M3.21M3.21M
EBITDA (Quarter)
-47.10M-51.16M-42.81M-39.81M-27.53M-28.24M-35.88M-25.39M-28.67M-18.45M-18.05M-17.38M-20.70M-14.27M-16.46M-10.33M-8.65M-13.85M-8.25M-8.27M
Interest Expenses (Quarter)
3.55M135.05M50.35M49.59M21.46M179.84M20.16M19.50M45.37M200.77M44.09M43.12M16.33M219.83M15.09M39.21M38.22M13.29M7.45M